Drug Profile
VN 0104
Alternative Names: VN-0104Latest Information Update: 27 Aug 2019
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Developer Japan Vaccine
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 31 Jul 2019 Discontinued - Phase-II for Influenza virus infections (Prevention) in Japan (SC) (Daiichi Sankyo pipeline, July 2019)